Search hospitals > Alabama > Birmingham
University of Alabama at Birmingham Cancer Center
Claim this profileBirmingham, Alabama 35233
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Breast Cancer
Conducts research for Brain Tumor
Conducts research for Tumors
663 reported clinical trials
37 medical researchers
Summary
University of Alabama at Birmingham Cancer Center is a medical facility located in Birmingham, Alabama. This center is recognized for care of Cancer, Leukemia, Breast Cancer, Brain Tumor, Tumors and other specialties. University of Alabama at Birmingham Cancer Center is involved with conducting 663 clinical trials across 598 conditions. There are 37 research doctors associated with this hospital, such as Victor T. Lin, Pankit Vachhani, Rebecca C. Arend, and Amitkumar Mehta, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Leukemia
Global LeaderStage II
CD5 positive
CD20 positive
Top PIs
Victor T. LinLouisiana Hematology Oncology Associates LLC9 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
25 reported clinical trials
65 drugs studied
Pankit VachhaniUniversity of Alabama at Birmingham2 years of reported clinical research
Studies Leukemia
Studies Acute Myeloid Leukemia
15 reported clinical trials
23 drugs studied
Rebecca C. ArendUniversity of Alabama at Birmingham Cancer Center1 year of reported clinical research
Studies Cancer
Studies Tumors
17 reported clinical trials
34 drugs studied
Amitkumar Mehta, MDUniversity of Alabama at Birmingham11 years of reported clinical research
Expert in Lymphoma
Studies Non-Hodgkin's Lymphoma
15 reported clinical trials
26 drugs studied
Clinical Trials running at University of Alabama at Birmingham Cancer Center
Breast Cancer
Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Renal Cell Carcinoma
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Lung Cancer
Bladder Cancer
Recurrence
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Alabama at Birmingham Cancer Center?
University of Alabama at Birmingham Cancer Center is a medical facility located in Birmingham, Alabama. This center is recognized for care of Cancer, Leukemia, Breast Cancer, Brain Tumor, Tumors and other specialties. University of Alabama at Birmingham Cancer Center is involved with conducting 663 clinical trials across 598 conditions. There are 37 research doctors associated with this hospital, such as Victor T. Lin, Pankit Vachhani, Rebecca C. Arend, and Amitkumar Mehta, MD.
Where is University of Alabama at Birmingham Cancer Center located?
The UAB Comprehensive Cancer Center is situated at 1824 6th Ave S, Birmingham, AL 35233. For appointments at the UAB Women & Infants Center and Hazelrig-Salter Radiation Oncology Center, valet parking is offered at the entrance, with an alternative to self-park in the deck located at 4th Avenue and 18th Street South. The main parking deck for patients and guests attending UAB Hospital is also at 4th Avenue and 18th Street South.
Who should I call to ask about financial aid or insurance network?
For financial assistance at the University of Alabama at Birmingham (UAB) Cancer Center, contact UAB Medicine Patient Billing Solutions at (205) 934-6400 or toll-free at (888) 309-8435. For insurance inquiries, call the main switchboard at (205) 934-4011. Hearing-impaired individuals can reach out via the TDD line at (205) 934-4642.
What insurance does University of Alabama at Birmingham Cancer Center accept?
The University of Alabama at Birmingham Cancer Center accepts various insurance plans, including Blue Cross and Blue Shield of Alabama, Viva Health, and Blue Cross/Blue Shield. Accepted plans include Viva UAB, Viva Access, and Blue Cross/Blue Shield's nationwide PPO network, covering one annual eye exam and offering student and sabbatical riders for out-of-network services. Additionally, the University of Alabama at Birmingham National Alumni Society offers life, health, travel, and other insurance plans for alumni and their families.
What awards or recognition has University of Alabama at Birmingham Cancer Center received?
The University of Alabama at Birmingham Comprehensive Cancer Center is the only National Cancer Institute-designated comprehensive cancer center in a six-state area, serving Alabama, Arkansas, Georgia, Louisiana, Mississippi, and South Carolina. It is renowned for its excellence in cancer research and patient care, earning rankings among the top institutions in the Southeast and the nation by U.S. News. Additionally, it has been recognized as a Magnet-designated organization by the American Nurses Credentialing Center Magnet Recognition Program® for the fifth consecutive time and named a Health Care Equality Leader by the Human Rights Campaign Foundation.